BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 12, 2017
View Archived Issues
Takeda and NuBiyota enter collaboration for the development of microbiome therapeutics
Read More
Discovery and preclinical characterization of novel MPS1 inhibitor CCT-289346
Read More
Ono describes selective ITK inhibitors for inflammatory disorders
Read More
Dual EZH1/2 inhibitor OR-S-1 shows promise in models of multiple myeloma, mantle cell lymphoma
Read More
Emulate signs multi-year collaborative agreement with the FDA
Read More
HER2-TTC, a novel HER2-targeted Th-227 conjugate with promising efficacy in cancer models
Read More
Arqule receives clearance for ARQ-531 phase I study
Read More
Meprin B involved in N-terminal truncated beta-amyloid generation in the brain
Read More
AzurRx Biopharma's phase II study of MS-1819 expected to complete Q3 2017
Read More
6XFAD Alzheimer's disease model displays both amyloid and tau pathology
Read More
FDA issues EAU for Nanobiosym Diagnostics' Zika virus test
Read More
Medix obtains approval to initiate phase III study of tesofensine
Read More
Mission Therapeutics and University of Oxford receive research grant from MJFF
Read More
FDA grants approval for Ingrezza capsules for adults with tardive dyskinesia
Read More
ARGX-110 enters phase II testing as a monotherapy in patients with relapsed/refractory CTCL
Read More
GlaxoSmithKline identifies novel IDO-1 inhibitors
Read More
LegoChem Biosciences patents anti-CD19 and anti-EGFR antibody-drug conjugates
Read More
Janssen describes novel BACE inhibitors
Read More
SOTIO gains rights to oncology program from Lead Discovery Center
Read More
BMS and Apexigen to evaluate Opdivo in combination with APX-005-M
Read More
Keystone Nano announces progress on RNA delivery using its proprietary NanoJackets
Read More
CDCN and Janssen enter a research collaboration to conduct a proteomics study of iMCD
Read More
National Immunotherapy Coalition formed to accelerate next-generation standard of care in cancer
Read More
French authorities grant Eyevensys approval to advance EyeCET platform
Read More